Escalon Medical Corp
Escalon Medical Corp. engages in the development, manufacturing, marketing, and distribution of medical devices and pharmaceuticals for ophthalmic applications in the United States and internationally. It offers A-Scan, which provides information about the internal structure of the eye; B-Scan, a diagnostic tool that supplies information to physicians where the media within the eye are cloudy or … Read more
Escalon Medical Corp (ESMC) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.051x
Based on the latest financial reports, Escalon Medical Corp (ESMC) has a cash flow conversion efficiency ratio of 0.051x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($85.01K) by net assets ($1.68 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Escalon Medical Corp - Cash Flow Conversion Efficiency Trend (2001–2025)
This chart illustrates how Escalon Medical Corp's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Escalon Medical Corp Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Escalon Medical Corp ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Hutchison Telecommunications (Australia) Ltd
AU:HTA
|
0.783x |
|
Leveljump Healthcare Corp
OTCQB:JMPHF
|
0.065x |
|
Graphene & Solar Technologies Limited
PINK:GSTX
|
0.035x |
|
Akash Infra-Projects Limited
NSE:AKASH
|
0.021x |
|
Commander Resources Ltd
PINK:CMDRF
|
-0.123x |
|
JADE ROAD INVESTMENTS LTD
F:1CP0
|
N/A |
|
SUREFIRE RES
F:GBL
|
N/A |
|
Blue Chip India Limited
NSE:BLUECHIP
|
-0.010x |
Annual Cash Flow Conversion Efficiency for Escalon Medical Corp (2001–2025)
The table below shows the annual cash flow conversion efficiency of Escalon Medical Corp from 2001 to 2025.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-06-30 | $1.92 Million | $380.73K | 0.199x | +159.68% |
| 2024-06-30 | $1.81 Million | $-602.77K | -0.333x | -298.22% |
| 2023-06-30 | $1.93 Million | $325.15K | 0.168x | +123.66% |
| 2022-06-30 | $1.48 Million | $-1.05 Million | -0.710x | -223.65% |
| 2021-06-30 | $1.46 Million | $838.71K | 0.574x | +615.50% |
| 2020-06-30 | $1.51 Million | $-168.50K | -0.111x | +49.02% |
| 2019-06-30 | $2.16 Million | $-472.69K | -0.219x | -594.07% |
| 2018-06-30 | $2.41 Million | $106.74K | 0.044x | +110.35% |
| 2017-06-30 | $1.18 Million | $-506.00K | -0.428x | +31.77% |
| 2016-06-30 | $1.91 Million | $-1.20 Million | -0.627x | -310.34% |
| 2015-06-30 | $2.99 Million | $-456.53K | -0.153x | +15.05% |
| 2014-06-30 | $3.46 Million | $-622.61K | -0.180x | +64.41% |
| 2013-06-30 | $3.83 Million | $-1.93 Million | -0.505x | +53.50% |
| 2012-06-30 | $644.87K | $-700.57K | -1.086x | -840.27% |
| 2007-06-30 | $39.41 Million | $5.78 Million | 0.147x | +8.85% |
| 2004-06-30 | $23.46 Million | $3.16 Million | 0.135x | -44.49% |
| 2003-06-30 | $8.94 Million | $2.17 Million | 0.243x | -13.90% |
| 2002-06-30 | $7.19 Million | $2.03 Million | 0.282x | +42.37% |
| 2001-06-30 | $6.11 Million | $1.21 Million | 0.198x | -- |